中国疾控中心出书 漫画解读埃博拉病毒被打败

2014-10-23 中国疾控中心 人民网-健康卫生频道

近日中国疾控中心制作出版《埃博拉病毒被打败》,采用漫画形式深入浅出地解答了关于埃博拉病毒的一系列问题,以期增强读者对疫情防范的信心,并帮助青少年掌握卫生知识,增强科学素养。 《埃博拉病毒被打败》漫画内容如下(前21张): ······

近日中国疾控中心制作出版《埃博拉病毒被打败》,采用漫画形式深入浅出地解答了关于埃博拉病毒的一系列问题,以期增强读者对疫情防范的信心,并帮助青少年掌握卫生知识,增强科学素养。


《埃博拉病毒被打败》漫画内容如下(前21张):


······

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]
    2014-10-25 zutt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1650306, encodeId=d8451650306e8, content=<a href='/topic/show?id=9e424155935' target=_blank style='color:#2F92EE;'>#埃博拉病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41559, encryptionId=9e424155935, topicName=埃博拉病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b24003788, createdName=tcm107hq, createdTime=Tue Jun 30 07:18:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2048275, encodeId=d9fc20482e54f, content=<a href='/topic/show?id=f8062191152' target=_blank style='color:#2F92EE;'>#中国疾控#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21911, encryptionId=f8062191152, topicName=中国疾控)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c32257, createdName=DEXTER3139, createdTime=Sun Jan 11 01:18:00 CST 2015, time=2015-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296414, encodeId=28311296414a3, content=<a href='/topic/show?id=76f941560d7' target=_blank style='color:#2F92EE;'>#埃博拉病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41560, encryptionId=76f941560d7, topicName=埃博拉病毒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=85aa264, createdName=redcrab, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405296, encodeId=65db1405296c1, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493427, encodeId=6328149342ef7, content=<a href='/topic/show?id=34846665532' target=_blank style='color:#2F92EE;'>#漫画#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66655, encryptionId=34846665532, topicName=漫画)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=zhangpaul93, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530227, encodeId=e1ea153022e3a, content=<a href='/topic/show?id=5b3d21912a7' target=_blank style='color:#2F92EE;'>#中国疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21912, encryptionId=5b3d21912a7, topicName=中国疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd912073499, createdName=tcm103hq, createdTime=Sat Oct 25 07:18:00 CST 2014, time=2014-10-25, status=1, ipAttribution=)]

相关资讯

Lancet:埃博拉疫情的控制(评论)

尽管埃博拉传染病很容易控制,但是目前已失去控制。控制传染病的关键是快速诊断,隔离和治疗。上次埃博拉爆发时,采用的方法是接触者追踪法,凡是和埃博拉患者接触过的人都要被监控并检查是否具有感染症状,如果被感染将会被安全地转移至医疗机构进行治疗。研究表明,未接受治疗的患者死亡率为60-90%,通过有效的治疗,死亡率可下降至30%。然而该方法并没有及时的应用于此次西非的埃博拉疫情中。根据美国疾控中心的估算,

Lancet:埃博拉临床试验,也一定要求随机对照?

当前在西非爆发的埃博拉疫情是有史以来最大和最复杂的情形,WHO已经宣布了引发国际关注的公共卫生紧急状态。两个月前,当西非埃博拉病毒感染死亡人数仅几百例时,WHO即发表了一项关于试验性药物及疫苗的重要声明,强调鉴于危机严重,提供可能有潜在益处但疗效及副作用尚不明确的试验性药物是符合伦理的,虽然尚需尽一切努力评估风险和收益并共享全部数据。随着当地病例数量的指数增长及卫生健康系统的崩溃,对药物和疫苗的需

埃博拉疫苗推迟上市

随着埃博拉病例的持续攀升,埃博拉疫苗成为了众人瞩目的焦点。今年8月28日,英国牛津大学称其詹纳研究所,将对美国国立卫生研究院(NIH)和英国葛兰素史克(GSK)公司联合研发的埃博拉疫苗展开临床试验,并可能在今年年底确定此疫苗的安全性。如果疫苗被证明在人类身体上使用安全,那么其将会尽快投入使用。美国多个新药审批的相关部门也表示,会对此疫苗的研究和上市大“开绿灯”。 疫苗公司已经在非洲开始试验

埃博拉新病例或曝美防疫漏洞

15日,载有美国第二例本土感染者文森的医疗飞机返回达拉斯。 美国15日证实出现第二例本土感染埃博拉病例,而患者观察期内乘飞机出行,让同机100多名乘客面临感染风险。美国媒体评论,虽然不知道这名护士如何感染埃博拉病毒,但她出行无阻且置同机乘客于风险中的情况反映出,美国号称的全球最先进医疗体系已有安全漏洞。 针对美国接连出现本土感染埃博拉病例,美国总统贝拉克·奥巴马15日说,美

埃博拉出血热医院感染预防与控制实用手册(援非医疗队)

本手册由卫计委组织国内专家根据埃博拉医院感染防控指南编写,供我国援非医疗队参考。参与编写的专家包括北京大学第一医院李六亿教授、解放军总医院刘运喜教授、中华医院感染学杂志魏华主任、北京安贞医院孟黎辉主任、北京友谊医院邓明卓主任、北京大学第三医院袁晓宁主任等,对他们的辛勤劳动,谨表谢意!也希望我们的援非战士能够平安凯旋。

埃博拉零距离,中国流行病学专家带你走进几内亚

“什么?去几内亚?”在得到了这个消息后,我的大脑在经过短暂的罢工后终于又重新工作了,接着便是出发前种种忐忑。在埃博拉新闻铺天盖地,局势如此动荡不安的时候,几内亚到底是什么样子呀。 但是工作就是这样,该来的总会来,2014年9月20日早上,作为卫计委派驻几内亚的第三批专家组的成员之一,我们一行三人从北京出发了。我们这个小组,除了我,还有来自北京大学第三附属医院么改琦和北京地坛医院的王凌航两位医